Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

November 30, 2000

Conditions
HIV Infections
Interventions
BIOLOGICAL

Dendritic Cells Pulsed with HIV antigens

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00058734 - Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients | Biotech Hunter | Biotech Hunter